Comparison of vasopressin and oxytocin receptors in the rat uterus and vascular tissue

By Anouar A.   Clerget M.-S.   Durroux T.   Barberis C.   Germain G.  

European Journal of Pharmacology, Vol. 308, Iss. 1, 1996-07 ,pp. : 87-96

Elsevier

Access to resources Recommend Favorite

[Arg 8 ]Vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists

By Bax W.A.   Van der Graaf P.H.   Stam W.B.   Bos E.   Nisato D.   Saxena P.R.  

European Journal of Pharmacology, Vol. 285, Iss. 2, 1995-10 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite

EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V_1a AND V₂ RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS

By Yatsu T.   Kusayama T.   Tomura Y.   Arai Y.   Aoki M.   Tahara A.   Wada K-I.   Tsukada J.  

Pharmacological Research, Vol. 46, Iss. 5, 2002-11 ,pp. : 375-381

Academic Press

Access to resources Recommend Favorite

Vasopressin-induced sensitization: involvement of neurohypophyseal peptide receptors

By Poulin P.   Szot P.   Dorsa D.M.   Pittman Q.J.  

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 29-39

Elsevier

Access to resources Recommend Favorite

The behavioral effect of vasopressin in the ventral hippocampus is antagonized by an oxytocin receptor antagonist

By Paban V.   Alescio-Lautier B.   Devigne C.   Soumireu-Mourat B.  

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 165-173

Elsevier

Access to resources Recommend Favorite